Logo image of NAC

NUVEEN CA QLTY MUNI INC (NAC) Stock Price, Quote, News and Overview

NYSE:NAC - New York Stock Exchange, Inc. - US67066Y1055 - Currency: USD

10.94  +0.09 (+0.83%)

After market: 10.94 0 (0%)

Fundamental Rating

2

Taking everything into account, NAC scores 2 out of 10 in our fundamental rating. NAC was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of NAC have multiple concerns. NAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAC had negative earnings in the past year.
In the past year NAC had a positive cash flow from operations.
In multiple years NAC reported negative net income over the last 5 years.
Each year in the past 5 years NAC had a positive operating cash flow.
NAC Yearly Net Income VS EBIT VS OCF VS FCFNAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -1.14%
ROE -1.95%
ROIC 0.34%
ROA(3y)-3.61%
ROA(5y)0.06%
ROE(3y)-6.03%
ROE(5y)-0.15%
ROIC(3y)N/A
ROIC(5y)N/A
NAC Yearly ROA, ROE, ROICNAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

Industry RankSector Rank
OM 16.44%
PM (TTM) N/A
GM 17.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAC Yearly Profit, Operating, Gross MarginsNAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NAC remains at a similar level compared to 1 year ago.
NAC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NAC is higher compared to a year ago.
NAC Yearly Shares OutstandingNAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
NAC Yearly Total Debt VS Total AssetsNAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

NAC has an Altman-Z score of 0.72. This is a bad value and indicates that NAC is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NAC is 12.37, which is on the high side as it means it would take NAC, 12.37 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.70 indicates that NAC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.37
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
NAC Yearly LT Debt VS Equity VS FCFNAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.20 indicates that NAC has no problem at all paying its short term obligations.
A Quick Ratio of 2.20 indicates that NAC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2
NAC Yearly Current Assets VS Current LiabilitesNAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

NAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.73%, which is quite impressive.
The Revenue has grown by 26.43% in the past year. This is a very strong growth!
NAC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.14% yearly.
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.58%
Revenue 1Y (TTM)26.43%
Revenue growth 3Y-50.39%
Revenue growth 5Y-35.14%
Sales Q2Q%20313.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAC Yearly Revenue VS EstimatesNAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAC Price Earnings VS Forward Price EarningsNAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.71
EV/EBITDA N/A
NAC Per share dataNAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NAC has a Yearly Dividend Yield of 7.49%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.45, NAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.49%

5.2 History

NAC has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NAC decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NAC Yearly Dividends per shareNAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of NAC are negative and hence is the payout ratio. NAC will probably not be able to sustain this dividend level.
DP-203.46%
EPS Next 2YN/A
EPS Next 3YN/A
NAC Yearly Income VS Free CF VS DividendNAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

More info and screens

NUVEEN CA QLTY MUNI INC

NYSE:NAC (4/30/2025, 8:23:41 PM)

After market: 10.94 0 (0%)

10.94

+0.09 (+0.83%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-02 2022-05-02
Earnings (Next)N/A N/A
Inst Owners18.11%
Inst Owner Change-0.1%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.58B
Analysts45
Price TargetN/A
Short Float %0.2%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield 7.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-203.46%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.93
P/FCF 15.71
P/OCF 15.71
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY6.37%
OCF(TTM)0.7
OCFY6.37%
SpS0.55
BVpS12.31
TBVpS12.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE -1.95%
ROCE 0.43%
ROIC 0.34%
ROICexc 0.34%
ROICexgc 0.34%
OM 16.44%
PM (TTM) N/A
GM 17.16%
FCFM 126.87%
ROA(3y)-3.61%
ROA(5y)0.06%
ROE(3y)-6.03%
ROE(5y)-0.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.37
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 0.72
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.43%
Revenue growth 3Y-50.39%
Revenue growth 5Y-35.14%
Sales Q2Q%20313.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.12%
FCF growth 3Y16.83%
FCF growth 5YN/A
OCF growth 1Y-12.12%
OCF growth 3Y16.83%
OCF growth 5YN/A